Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments

The CHMP is urging the EU research community to prioritise RCTs because they are most likely to generate the conclusive evidence needed to enable rapid development and approval of potential treatments of COVID-19.


European Medicines Agency